Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type i diabetes via oxidative stress and ACE2

Experimental Diabetes Research

Volumn 2011, Issue , 2011, Pages

  Chang, Shiao Ying ^a   Chen, Yun Wen ^a   Chenier, Isabelle ^a   Tran, Stella Le Minh ^a   Zhang, Shao Ling ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; HEME OXYGENASE 1; INSULIN; PROTEIN; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; ANGIOTENSIN 2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY HYPERTROPHY; KIDNEY PROXIMAL TUBULE; KIDNEY STRUCTURE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; KIDNEY; MALE; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PEPTIDYL-DIPEPTIDASE A; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM;

EID: 84555179145     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2011/521076     Document Type: Article

References (41)

1. Breyer M. D., Diabetic nephropathy: introduction Seminars in Nephrology 2007 27 2 129 (Pubitemid 46550313)
2. Gross J. L., de Azevedo M. J., Silveiro S. P., Canani L. H., Caramori M. L., Zelmanovitz T., Diabetic nephropathy: diagnosis, prevention, and treatment Diabetes Care 2005 28 1 164 176 (Pubitemid 40095801)
3. Jacobsen P. K., Rossing P., Parving H. H., Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy Nephrology Dialysis Transplantation 2006 21 7 2030 2031 (Pubitemid 43985751)
4. Parving H. H., de Zeeuw D., Cooper M. E., Remuzzi G., Liu N., Lunceford J., Shahinfar S., Wong P. H., Lyle P. A., Rossing P., Brenner B. M., ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy Journal of the American Society of Nephrology 2008 19 4 771 779
5. Schjoedt K. J., Hansen H. P., Tarnow L., Rossing P., Parving H. H., Long-term prevention of diabetic nephropathy: an audit Diabetologia 2008 51 6 956 961
6. Ritz E., Schmieder R. E., Pollock C. A., Renal protection in diabetes: lessons from ONTARGET Cardiovascular Diabetology 2010 9, article 60
7. Ozono R., Wang Z. Q., Moore A. F., Inagami T., Siragy H. M., Carey R. M., Expression of the subtype 2 angiotensin (AT 2) receptor protein in rat kidney Hypertension 1997 30 5 1238 1246 (Pubitemid 27476185)
8. Ichiki T., Labosky P. A., Shiota C., Okuyama S., Imagawa Y., Fogo A., Niimura F., Ichikawa I., Hogan B. L. M., Inagami T., Effects on blood pressure exploratory behaviour of mice lacking angiotensin II type 2 receptor Nature 1995 377 6551 748 750
9. Nishimura H., Yerkes E., Hohenfellner K., Miyazaki Y., Ma J., Hunley T. E., Yoshida H., Ichiki T., Threadgill D., Phillips J. A., Hogan B. M. L., Fogo A., Brock J. W., Inagami T., Ichikawa I., Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men Molecular Cell 1999 3 1 1 10 (Pubitemid 29292472)
10. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R. E., Acton S., A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 Circulation Research 2000 87 5 E1 9
11. Tipnis S. R., Hooper N. M., Hyde R., Karran E., Christie G., Turner A. J., A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase Journal of Biological Chemistry 2000 275 43 33238 33243
12. Ferrario C. M., Chappell M. C., Tallant E. A., Brosnihan K. B., Diz D. I., Counterregulatory actions of angiotensin-(1-7) Hypertension 1997 30 3 535 541 (Pubitemid 27444228)
13. Ingelfinger J. R., Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease Current Opinion in Nephrology and Hypertension 2009 18 1 79 84
14. Koka V., Xiao R. H., Chung A. C. K., Wang W., Truong L. D., Lan H. Y., Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway American Journal of Pathology 2008 172 5 1174 1183 (Pubitemid 351671532)
15. Hunley T. E., Tamura M., Stoneking B. J., Nishimura H., Ichiki T., Inagami T., Kon V., The angiotensin type II receptor tonically inhibits angiotensin-converting enzyme in AT2 null mutant mice Kidney International 2000 57 2 570 577 (Pubitemid 30430649)
16. Liu F., Brezniceanu M. L., Wei C. C., Chénier I., Sachetelli S., Zhang S. L., Filep J. G., Ingelfinger J. R., Chan J. S. D., Overexpression of angiotensinogen increases tubular apoptosis in diabetes Journal of the American Society of Nephrology 2008 19 2 269 280 (Pubitemid 351240649)
17. Liu F., Wei C. C., Wu S. J., Chenier I., Zhang S. L., Filep J. G., Ingelfinger J. R., Chan J. S. D., Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension Kidney International 2009 75 2 156 166
18. Sachetelli S., Liu Q., Zhang S. L., Liu F., Hsieh T. J., Brezniceanu M. L., Guo D. F., Filep J. G., Ingelfinger J. R., Sigmund C. D., Hamet P., Chan J. S. D., RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney Kidney International 2006 69 6 1016 1023 (Pubitemid 43372176)
19. Qi Z., Fujita H., Jin J., Davis L. S., Wang Y., Fogo A. B., Breyer M. D., Characterization of susceptibility of inbred mouse strains to diabetic nephropathy Diabetes 2005 54 9 2628 2637 (Pubitemid 41233584)
20. Brezniceanu M. L., Liu F., Wei C. C., Chénier I., Godin N., Zhang S. L., Filep J. G., Ingelfinger J. R., Chan J. S. D., Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells Diabetes 2008 57 2 451 459
21. Brezniceanu M. L., Wei C. C., Zhang S. L., Hsieh T. J., Guo D. F., Hébert M. J., Ingelfinger J. R., Filep J. G., Chan J. S. D., Transforming growth factor-beta 1 stimulates angiotensinogen gene expression in kidney proximal tubular cells Kidney International 2006 69 11 1977 1985 (Pubitemid 43924261)
22. Tolivia J., Navarro A., Del Valle E., Perez C., Ordoez C., Martnez E., Application of photoshop and scion image analysis to quantification of signals in histochemistry, immunocytochemistry and hybridocytochemistry Analytical and Quantitative Cytology and Histology 2006 28 1 43 53 (Pubitemid 43334519)
23. Tran S., Chen Y. W., Chenier I., Chan J. S. D., Quaggin S., Hébert M. J., Ingelfinger J. R., Zhang S. L., Maternal diabetes modulates renal morphogenesis in offspring Journal of the American Society of Nephrology 2008 19 5 943 952
24. Brezniceanu M. L., Liu F., Wei C. C., Tran S., Sachetelli S., Zhang S. L., Guo D. F., Filep J. G., Ingelfinger J. R., Chan J. S. D., Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice Kidney International 2007 71 9 912 923 (Pubitemid 46663797)
25. Godin N., Liu F., Lau G. J., Brezniceanu M. L., Chénier I., Filep J. G., Ingelfinger J. R., Zhang S. L., Chan J. S., Catalase overexpression prevents hypertension and tubular apoptosis in angiotensinogen transgenic mice Kidney International 2010 77 12 1086 1097
26. Ferrario C. M., Jessup J., Gallagher P. E., Averill D. B., Brosnihan K. B., Tallant E. A., Smith R. D., Chappell M. C., Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors Kidney International 2005 68 5 2189 2196 (Pubitemid 43117793)
27. Siragy H. M., Angiotensin AT1 and AT2 receptorsthe battle for health and disease Nephrology Dialysis Transplantation 2007 22 11 3128 3130 (Pubitemid 350202592)
28. Siragy H. M., Inagami T., Carey R. M., NO and cGMP mediate angiotensin AT 2 receptor-induced renal renin inhibition in young rats American Journal of Physiology 2007 293 4 R1461 R1467
29. Carey R. M., Padia S. H., Angiotensin AT 2 receptors: control of renal sodium excretion and blood pressure Trends in Endocrinology and Metabolism 2008 19 3 84 87 (Pubitemid 351442917)
30. Jhren O., Dendorfer A., Dominiak P., Cardiovascular and renal function of angiotensin II type-2 receptors Cardiovascular Research 2004 62 3 460 467 (Pubitemid 38648960)
31. Ma J., Nishimura H., Fogo A., Kon V., Inagami T., Ichikawa I., Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction Kidney International 1998 53 4 937 944 (Pubitemid 28155667)
32. Jerums G., Panagiotopoulos S., Premaratne E., MacIsaac R. J., Integrating albuminuria and GFR in the assessment of diabetic nephropathy Nature Reviews Nephrology 2009 5 7 397 406
33. Sourris K. C., Morley A. L., Koitka A., Samuel P., Coughlan M. T., Penfold S. A., Thomas M. C., Bierhaus A., Nawroth P. P., Yamamoto H., Allen T. J., Walther T., Hussain T., Cooper M. E., Forbes J. M., Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor Diabetologia 2010 53 11 2442 2451
34. Rster C., Bondeva T., Franke S., Tanaka N., Yamamoto H., Wolf G., Angiotensin II upregulates RAGE expression on podocytes: role of AT 2 receptors American Journal of Nephrology 2009 29 6 538 550
35. Asaba K., Tojo A., Onozato M. L., Goto A., Quinn M. T., Fujita T., Wilcox C. S., Effects of NADPH oxidase inhibitor in diabetic nephropathy Kidney International 2005 67 5 1890 1898 (Pubitemid 40577724)
36. Kitada M., Koya D., Sugimoto T., Isono M., Araki S. I., Kashiwagi A., Haneda M., Translocation of glomerular p47phox and p67phox by protein kinase C- activation is required for oxidative stress in diabetic nephropathy Diabetes 2003 52 10 2603 2614 (Pubitemid 37210551)
37. Rabelo L. A., Alenina N., Bader M., ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease Hypertension Research 2011 34 2 154 160
38. Benter I. F., Yousif M. H. M., Dhaunsi G. S., Kaur J., Chappell M. C., Diz D. I., Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats American Journal of Nephrology 2007 28 1 25 33 (Pubitemid 350126490)
39. Gonzales S., Noriega G. O., Tomaro M. L., Pea C., Angiotensin-(1-7) stimulates oxidative stress in rat kidney Regulatory Peptides 2002 106 1-3 67 70 (Pubitemid 34607339)
40. Zhong J., Guo D., Chen C. B., Wang W., Schuster M., Loibner H., Penninger J. M., Scholey J. W., Kassiri Z., Oudit G. Y., Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2 Hypertension 2011 57 314 322
41. Oudit G. Y., Liu G. C., Zhong J., Basu R., Chow F. L., Zhou J., Loibner H., Janzek E., Schuster M., Penninger J. M., Herzenberg A. M., Kassiri Z., Scholey J. W., Human recombinant ACE2 reduces the progression of diabetic nephropathy Diabetes 2010 59 2 529 538